241 related articles for article (PubMed ID: 26596412)
1. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups.
Kim Y; Hong M; Do IG; Ha SY; Lee D; Suh YL
Pathol Res Pract; 2015 Dec; 211(12):963-72. PubMed ID: 26596412
[TBL] [Abstract][Full Text] [Related]
2. ROR2 and Wnt5a expression in stage 1 pure testicular seminomas.
Lim SD; Kim WS; Kwon GY
Anal Quant Cytopathol Histpathol; 2013 Feb; 35(1):41-51. PubMed ID: 23469623
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining.
Hirano H; Yonezawa H; Yunoue S; Habu M; Uchida H; Yoshioka T; Kishida S; Kishida M; Oyoshi T; Fujio S; Sugata S; Yamahata H; Hanaya R; Arita K
Brain Tumor Pathol; 2014 Apr; 31(2):85-93. PubMed ID: 23748645
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.
Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J
Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508
[TBL] [Abstract][Full Text] [Related]
6. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
[TBL] [Abstract][Full Text] [Related]
7. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
8. Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma.
Wang L; Yang D; Wang YH; Li X; Gao HM; Lv JY; Wang L; Xin SJ
Tumour Biol; 2016 May; 37(5):6085-90. PubMed ID: 26608372
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Wu ZC; Xiong L; Wang LX; Miao XY; Liu ZR; Li DQ; Zou Q; Liu KJ; Zhao H; Yang ZL
World J Gastroenterol; 2017 Apr; 23(14):2601-2612. PubMed ID: 28465645
[TBL] [Abstract][Full Text] [Related]
10. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
11. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a.
Simonetti M; Kuner R
J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667
[TBL] [Abstract][Full Text] [Related]
12. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
Liu Y; Rubin B; Bodine PV; Billiard J
J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.
Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y
Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005
[TBL] [Abstract][Full Text] [Related]
15. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
[TBL] [Abstract][Full Text] [Related]
16. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway.
Oishi I; Suzuki H; Onishi N; Takada R; Kani S; Ohkawara B; Koshida I; Suzuki K; Yamada G; Schwabe GC; Mundlos S; Shibuya H; Takada S; Minami Y
Genes Cells; 2003 Jul; 8(7):645-54. PubMed ID: 12839624
[TBL] [Abstract][Full Text] [Related]
17. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
18. Ryk is essential for Wnt-5a-dependent invasiveness in human glioma.
Habu M; Koyama H; Kishida M; Kamino M; Iijima M; Fuchigami T; Tokimura H; Ueda M; Tokudome M; Koriyama C; Hirano H; Arita K; Kishida S
J Biochem; 2014 Jul; 156(1):29-38. PubMed ID: 24621529
[TBL] [Abstract][Full Text] [Related]
19. RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway.
Adamo A; Fiore D; De Martino F; Roscigno G; Affinito A; Donnarumma E; Puoti I; Ricci Vitiani L; Pallini R; Quintavalle C; Condorelli G
Oncotarget; 2017 Feb; 8(8):13476-13487. PubMed ID: 28086236
[TBL] [Abstract][Full Text] [Related]
20. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]